Ceftolozane/Tazobactam In-Vitro Activity against Clinical Isolates from Complicated Intra-Abdominal Infection Patients in Three Indonesian Referral Hospitals

• Main Authors: Anis Karuniawati (Author), Merry Ambarwulan (Author), Selvi Nafisa Shahab (Author), Yefta Moenadjat (Author), Toar J. M. Lalisang (Author), Neneng Dewi Kurniati (Author), Kuntaman (Author), Vicky Sumarki Budipramana (Author), Tomy Lesmana (Author), Iva Puspitasari (Author), Erik Prabowo (Author), Dwi Putranti Chitra Sasmitasari (Author), Dian Oktavianti Putri (Author), Amrilmaen Badawi (Author)
• Format: Book
• Published: MDPI AG, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Complicated intra-abdominal infections (cIAIs) lead to high morbidity and mortality, especially if poorly managed. However, Indonesia's microbial pattern and susceptibility data are limited, especially for new antibiotics. Ceftolozane/tazobactam (C/T) is reported to be a new potent antibiotic a...